Elevation of serum nepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue

Anticancer Research

Volumn 20, Issue 2 B, 2000, Pages 1263-1267

  Beppu, Kiichiro ^a   Uchiyama, Akihiko ^b   Morisaki, Takashi ^a   Nakamura, Kenjiro ^b   Noshiro, Hirokazu ^b   Matsumoto, Kunio ^c   Nakamura, Toshikazu ^c   Tanaka, Masao ^b   Katano, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Gastric cancer; Hepatocyte growth factor; Serum

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; SCATTER FACTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STOMACH CANCER; WESTERN BLOTTING; BIOSYNTHESIS; BLOOD; CANCER STAGING; INFLAMMATION; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH MUCOSA; STOMACH TUMOR;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRIC MUCOSA; HEPATOCYTE GROWTH FACTOR; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEOPLASM STAGING; STOMACH NEOPLASMS;

EID: 0033625690     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Nakamura T, Nawa K and Ichihara A: Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122: 1450-1459, 1984.
2. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K and Shimizu S: Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443, 1989.
3. Miyazawa K, Tsubouchi H, Naka D, Takahashi K, Okigaki M, Arakaki N, Nakayama H, Hirono S, Sakiyama O, Gohda E, Daikuhara Y and Kitamura N: Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 163: 967-973, 1989.
4. Zarnegar R and Michalopoulos GK: The many faces of hepatocyte growth factor: From hepatopoiesis to hematopoiesis. J Cell Biol 129: 1177-1180, 1995.
5. Matsumoto K and Nakamura T: Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 239: 639-644, 1997.
6. Birchmeier C and Gherardi E: Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 8: 404-410, 1998.
7. Noji S, Tashiro K, Koyama E, Nohno T, Ohyama K, Taniguchi S and Nakamura T: Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun 173: 42-47, 1990.
8. Matsumoto K, Okazaki H and Nakamura T: Up-regulation of hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts. Biochem Biophys Res Commun 188: 235-243, 1992.
9. Sonnenberg E, Meyer D, Weidner KM and Birchmeier C: Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase can mediate a signal exchange between mesenchymal and epithelia during mouse development. J Cell Biol 123: 223-235, 1993.
10. Weidner KM, Behrens J, Vandekerckhove J and Birchmeier W: Scatter factor: Molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol 111: 2097-2108, 1990.
11. Stoker M and Perryman M: An epithelial scatter factor released by embryo fibroblasts. J Cell Sci 77: 209-223, 1985.
12. Gherardi E, Gray J, Stoker M, Perryman M and Furlong R: Purification of scatter factor, a fibroblast-derived basic protein that modulate epithelial-mesenchymal interaction and movement. Proc Natl Acad Sci USA 86: 5844-5848, 1989.
13. Bottaro DP, Rubin JS, Faletto DL, Chan AML, Kmiecik TE, Vande Woude GF and Aaronson SA: Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251: 802-804, 1991.
14. Naldini L, Vigna E, Narsimhan RP, Gaudino G, Zarnegar R, Michalopoulas GK and Comoglio PM: Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene 6: 501-504, 1991.
15. Giordano S, Zhen Z, Medico E, Gaudino G, Galimi F and Comoglio PM: Transfer of motogenic and invasive response to scatter factor /hepatocyte growth factor by transfection of human MET protooncogene. Proc Natl Acad Sci USA 90: 649-653, 1993.
16. Jeffers M, Rong S/Vand Woude GF: Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-Met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol 16: 1115-1125, 1996.
17. Jiang WG and Hiscox S: Hepatocyte growth factor/scatter factor, a cytokine playing multiple and converse roles. Histol Histopathol 12: 537-555, 1997.
18. Tsubouchi H, Nitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, Sakiyama O, Takahashi K, Kimoto M, Kawakami S, Setoguchi M, Tachikawa T, Shin S, Arima T and Daikuhara Y: Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme linked immunosorbent assay. Hepatology 13: 1-5, 1991.
19. Ueda T, Takeyama Y, Toyokawa A, Kishida S, Yamamoto and Saitoh Y: Significant elevation of serum human hcpatocyte growth factor levels in patients with acutepancreatitis. Pancreas 12: 76-83, 1996.
20. Sakon M, Kita Y, Yoshida T, Umeshita K, Gotoh M, Kanai T, Kawasaki T, Kambayashi J and Monden M: Plasma hepatocyte growth factor levels are increased in systemic inflammatory response syndrome. Surg Today 26: 236-241, 1996.
21. Taniguchi T, Toi M, Inada K, Imazawa T, Yamamoto Y and Tominaga T: Serum concentrations of hepatocyte growth factor in breast cancer patients. Clin Cancer Res 1: 1031-1034, 1995.
22. Toi M, Taniguchi T, Ueno T, Asano M, Funata N, Sekiguchi K, Iwanari H and Tominaga T: Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer. Clin Cancer Res 4: 659-664, 1998.
23. Takigawa N, Segawa Y, Maeda Y, Takata and Fujimoto N: Serum hepatocyte growth factor/scatter factor levels in small cell lung cancer patients. Lung Cancer 17: 211-218, 1997.
24. Taniguchi T, Kitamura M, Arai K, Iwasaki Y, Yamamoto Y, Igari A and Toi M: Increase in the circulating level of hepatocyte growth factor in gastric cancer patients. Br J Cancer 75: 673-677, 1997.
25. Wu CW, Chi CW, Su TL, Liu TY, Lui WY and Peng FK: Serum hepatocyte growth factor level associate with gastric cancer progression. Anticancer Res 18: 5B: 3657-3659, 1998.
26. Miki M, Isozaki H, Toyoda M, Ishibashi T, Fujii K, Nomura E, Mabuchi E, Nakane, Nishiguchi, KI and Tanigawa N: Serum human hepatocyte growth factor (hHGF) is elevated in patients with gastric carcinoma. Hepatogastroentero 46: 568-573, 1999.
27. Fukuura T, Miki C, Inoue T, Matsumoto K and Suzuki H: Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma. Br J Cancer 78: 454-459, 1998.
28. Gofuku J, Shiozaki H, Doki Y, Inoue M, Hirano M, Fukuchi N and Monden M: Characterization of soluble E-cadherin as a disease marker in gastric cancer patients. Br J Cance 78: 1095-1101, 1998.
29. Yamashita J, Ogawa M, Yamashita S, Nomura K, Kuramoto M, Saishoji T and Shin S: Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 54: 1630-1633, 1994.
30. Nakamura T, Matsumoto K, Kiritoshi A, Tano Y and Nakamura T: Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: In vitro analysis of tumor-stromal interactions. Cancer Res 57: 3305-3313, 1997.
31. Yoshinaga Y, Matsuno Y, Fujita S, Nakamura T, Kikuchi M, Shimosato Y and Hirohashi S: Immunohistochemical detection of hepatocyte growth factor/scatter factor in human cancerous and inflammatory lesions of various organs. Jpn J Cancer Res 84: 1150-1158, 1993.
32. Rampino T, Libetta C, Simone WD, Ranghino A, Soccio G, Gregorini M, Guallini P, Tamagnone and Canton AD: Hemodialysis stimulates hepatocyte growth factor release. Kidney Int 53: 1382-1388, 1998.
33. Boros P and Miller CM: Hepatocyte growth factor: A multifunctional cytokine. Lancet 345: 243-295, 1995.
34. Kopp A, Jonat W, Schmahl M and Knabbe C: Transforming growth factor β2 v (TGF-β2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen. Cancer Res 55: 4512-4515, 1995.
35. Kumar H, Heer K, Lee PWR, Duthie GS, MacDonald AW, Greenman J, Kerin M and Monson JRT: Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin Cancer Res 4: 1279-1285, 1998,
36. Takigawa N, Segawa Y, Fujimoto N, Hotta K and Eguchi K: Elevated vascular endothelial growth factor levels in sera of patients with lung cancer. Anticancer Res 18: 1251-1254, 1998.
37. Iizasa T, Fujisawa T, Suzuki M, Motohashi S, Yasufuku K, Yasukawa T, Baba M and Shiba M: Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients. Clin Cancer Res 5: 149-153, 1999.
38. Siegfried JM, Weissfeld LA, Singh-Kaw P, Weyant RJ, Testa JR and Landreneau RJ: Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer. Cancer Res 57: 433-439, 1997.